SYNGR3 and post-traumatic stress disorder: We believe that our work paves the way for the specific targeting of the presynaptic functions of Syn2a-Syngr3, both to selectively evaluate the contribution of this pathway to disease progression in animal models, as well as for providing future therapeutic approaches by targeting synaptic dysfunction in PTSD.